The European Union has released Guidelines to provide legal clarity on the prohibited uses of AI within the EU AI Act to ensure effective, consistent and uniform application and protect European citizens' rights and safety.
The EU AI Act, which outlines regulations for the development, market placement, implementation and use of artificial intelligence in the European Union, came into effect in...
On his first day in office of his second term, President Donald Trump revoked Joe Biden's 2023 executive order, which aimed to establish standards for the safe, secure and trustworthy development of AI across various sectors, including healthcare.
Among its many provisions, Biden's order directed the U.S. Department of Health and Human Services (HHS) to establish a safety program "to help ensure...
At a Boston Consulting Group (BCG) event in San Francisco during the JPM Healthcare Conference taking place this week, panelists discussed the government's role in advancing AI technology and government oversight of the technology with the changing administration.
Micky Tripathi, assistant secretary for technology policy, national coordinator for health IT and chief AI officer for the U.S....
The Food and Drug Administration (FDA) has released its perspective on regulating AI in healthcare and biomedicine, stating that oversight needs to be coordinated across all regulated industries, international organizations and the U.S. government.
The Agency says it regulates industries that distribute their products to the global market, and therefore U.S. regulatory standards must be...
The EU AI Act comes into effect today, outlining regulations for the development, market placement, implementation and use of artificial intelligence in the European Union.
The Council wrote that the Act is intended to "promote the uptake of human-centric and trustworthy artificial intelligence while ensuring a high level of protection of health, safety, [and] fundamental rights … including...
Note: Andreessen Horowitz says views expressed by its employees are their own and should not be taken as investment advice. More details at https://a16z.com/disclosures/.
As 2023 comes to a close, Jay Rughani, investment partner at Andreessen Horowitz, joined MobiHealthNews to discuss his takeaways from the year, noteworthy events, recommendations for regulators forming rules around AI in...
Dr. Michael Howell, chief clinical officer at Google, sat down with MobiHealthNews to discuss noteworthy events in 2023, the evolution of the company's LLM for healthcare, called Med-PaLM, and recommendations for regulators in constructing rules around the use of artificial intelligence in the sector.
MobiHealthNews: What are some of your big takeaways from 2023?
Dr. Michael Howell: For us,...